Tips for approaching the diagnosis of advanced stage GU cancers during COVID-19
[ad_1]
Clayton Lau, MD, advises primary care physicians and specialists on how to combat the growing prevalence of advanced genitourinary cancers.
Clayton Lau, MD, Chief, Division of Urology and Urologic Oncology, Director, Prostate Cancer Program, Chief, Retroperitoneal Surgery, Clinical Associate Professor, City of Hope Comprehensive Cancer Center Department of Surgery, advises physicians primary care providers and specialists on how to help combat the growing prevalence of advanced genitourinary (GU) cancers.
According to a recent interview with Lau, there have been a large number of patients with advanced illness during the COVID-19 pandemic. Much of the problem has to do with lack of screening, late screening, and patients not seeing the doctor.
Lau believes that suppliers can be part of the solution in the future.
Transcription:
0: 08 | I think it’s important for the doctors, you know, especially the primary care doctors or even the specialists, to tell their patients or educate the patients to continue screening. You know, for GU cancers, certainly for patients who have first-sighted relatives who have prostate cancer, they probably should be screened earlier than traditionally. So start screening patients at age 40.
0: 33 | As well, [for] African Americans are certainly considering skipping this conversation sooner. You know, consider screening at 40 or 45, with PSA, rectal exam, and maybe even MRI to help determine if they have anything that needs a biopsy. But it’s important for all doctors, you know, to get their patients screened for all GU cancers and other cancers.
[ad_2]
